Full Value Chain

Our major therapeutic areas include oncology, autoimmune, cardiovascular, respiratory and anti-infectives. We are commited to provide indispensable products and key values to clinicians and patients. 

At the same time, we leverage strong in-house innovation capabilities to actively explore global partnerships for proprietary R&D projects. We aim at exploring and cultivating clinical development and commercialization for mainstream overseas pharmaceutical markets.

We have international-standarded manufacturing facilities and our factories have achieved full business process informatization for industrial operations. We follow the global drug quality control standards to fulfill our commitment of being patient-centered.

We are one of the few local biopharmaceutical companies with a global supply chain management capability that ensures us to have sustainable product supply and cost advantages, establish competitive barriers, and acquire conditions for the continuous acquisition and localization transfer of subsequent pipeline products in the future.

Our academic-oriented sales and marketing strategy and data-based efficient operation improve drug accessibilities to the market. We dedicate to benefit more patients  from our classic products and innovative drugs.